US Patent Issued to MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH on June 16 for "SARS-CoV-2 polypeptides" (Minnesota, Florida Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,880, issued on June 16, was assigned to MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (Rochester, Minn.).

"SARS-CoV-2 polypeptides" was invented by Gregory A. Poland (Marco Island, Fla.), Inna G. Ovsyannikova (Rochester, Minn.) and Richard B. Kennedy (Rochester, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This document provides methods and materials related to selected severe acute respiratory distress coronavirus 2 (SARS-CoV-2) polypeptides. For example, this document provides vaccine compositions that contain one or more selected SARS-CoV-2 polypeptides provided herein and that have the ability to induce or increase immune responses ...